BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 31254517)

  • 1. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
    Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
    J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
    Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
    J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive diagnosis of early cutaneous squamous cell carcinoma.
    Azimi A; Jabbour S; Patrick E; Fernandez-Penas P
    Exp Dermatol; 2023 Nov; 32(11):1946-1959. PubMed ID: 37688398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical staining for p16 is a useful adjunctive test in the diagnosis of Bowen's disease.
    Harvey NT; Leecy T; Wood BA
    Pathology; 2013 Jun; 45(4):402-7. PubMed ID: 23635817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease.
    Talghini S; Halimi M; Baybordi H
    Pak J Biol Sci; 2009 Jun; 12(12):929-33. PubMed ID: 19777788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics: An emerging approach for the diagnosis and classification of cutaneous squamous cell carcinoma and its precursors.
    Azimi A; Kaufman KL; Kim J; Ali M; Mann GJ; Fernandez-Penas P
    J Dermatol Sci; 2020 Jul; 99(1):9-16. PubMed ID: 32312638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Immunohistochemical Localization of Fatty Acid Binding Protein 5 in Actinic Keratosis Compared with That in Bowen's Disease: A Retrospective Study.
    Ahn B; Kim CH; Chae YS; Lee JH; Lee Y; Ahn HH; Lee YJ
    Am J Dermatopathol; 2021 May; 43(5):356-361. PubMed ID: 33055535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16INK4a expression in actinic keratosis and Bowen's disease.
    Salama ME; Mahmood MN; Qureshi HS; Ma C; Zarbo RJ; Ormsby AH
    Br J Dermatol; 2003 Nov; 149(5):1006-12. PubMed ID: 14632806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention.
    Leiter U; Heppt MV; Steeb T; Alter M; Amaral T; Bauer A; Bechara FG; Becker JC; Breitbart EW; Breuninger H; Diepgen T; Dirschka T; Eigentler T; ElGammal AKS; Felcht M; Flaig MJ; Follmann M; Fritz K; Grabbe S; Greinert R; Gutzmer R; Hauschild A; Hillen U; Ihrler S; John SM; Kofler L; Koelbl O; Krause-Bergmann A; Kraywinkel K; Krohn S; Langer T; Loquai C; Löser CR; Mohr P; Nashan D; Nothacker M; Pfannenberg C; Salavastru C; Schmitz L; Stockfleth E; Szeimies RM; Ulrich C; Voelter-Mahlknecht S; Vordermark D; Weichenthal M; Welzel J; Wermker K; Wiegand S; Garbe C; Berking C
    J Dtsch Dermatol Ges; 2023 Nov; 21(11):1422-1433. PubMed ID: 37840404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.
    Riihilä PM; Nissinen LM; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
    J Invest Dermatol; 2014 Feb; 134(2):498-506. PubMed ID: 23938460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
    Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermoscopy of actinic keratosis, intraepidermal carcinoma and squamous cell carcinoma.
    Zalaudek I; Argenziano G
    Curr Probl Dermatol; 2015; 46():70-6. PubMed ID: 25561209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and significance of mammalian target of rapamycin in cutaneous squamous cell carcinoma and precancerous lesions.
    Xu G; Fang J; Xu J; Shen Z; Huang C; Jiang Y
    Bioengineered; 2021 Dec; 12(2):9930-9938. PubMed ID: 34874800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16 immunostaining in keratinocytic neoplasia in organ transplant recipients: Bowen's disease shows a characteristic pattern.
    Genders RE; Beck S; Bouwes Bavinck JN; van den Munckhof HA; Kouwenhoven ST; de Koning MN; de Gruijl FR; Jenkins D; Willemze R; Quint KD
    J Cutan Pathol; 2017 Jan; 44(1):28-33. PubMed ID: 27717097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical intraepidermal keratinocytic lesions falling short of carcinoma in situ (Bowen disease) on routine staining: the utility of p16 immunostaining.
    Ko C; Srisuttiyakorn C
    J Cutan Pathol; 2014 Dec; 41(12):975-7. PubMed ID: 25558038
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma.
    Ito T; Tsuji G; Ohno F; Nakahara T; Uchi H; Furue M
    Mod Pathol; 2017 Jul; 30(7):919-927. PubMed ID: 28339425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of Werner protein as an early DNA damage response in actinic keratosis, Bowen disease and squamous cell carcinoma.
    Cha HJ; Lee DB; Jung HN; Choi YS; Suh HS
    Clin Exp Dermatol; 2015 Jul; 40(5):564-9. PubMed ID: 25545408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The characteristics of human papillomavirus expression and cell proliferation in actinic keratosis and Bowen's disease of the skin.
    Kvlividze O; Gogiashvili L; Burkadze G
    Georgian Med News; 2006 Jul; (136):108-12. PubMed ID: 16905862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.